These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 11026036)

  • 1. [Allelic loss as prognostic factor in breast cancer].
    Utada Y; Emi M; Haga S; Kajiwara T
    Nihon Rinsho; 2000 Apr; 58 Suppl():473-7. PubMed ID: 11026036
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prognostic significance of loss of heterozygosity in breast cancer].
    Iwase H; Iwata H; Toyama T; Hara Y; Omoto Y; Kobayashi S
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():426-30. PubMed ID: 9589047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic loss at the 8p22 region as a prognostic factor in large and estrogen receptor negative breast carcinomas.
    Utada Y; Haga S; Kajiwara T; Kasumi F; Sakamoto G; Nakamura Y; Emi M
    Cancer; 2000 Mar; 88(6):1410-6. PubMed ID: 10717624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic loss at 1p34, 13q12, 17p13.3, and 17q21.1 correlates with poor postoperative prognosis in breast cancer.
    Emi M; Yoshimoto M; Sato T; Matsumoto S; Utada Y; Ito I; Minobe K; Iwase T; Katagiri T; Bando K; Akiyama F; Harada Y; Fukino K; Sakamoto G; Matsushima M; Iida A; Tada T; Saito H; Miki Y; Kasumi F; Nakamura Y
    Genes Chromosomes Cancer; 1999 Oct; 26(2):134-41. PubMed ID: 10469451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic loss at 1p34-36 predicts poor prognosis in node-negative breast cancer.
    Utada Y; Emi M; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Haga S; Kajiwara T; Nakamura Y
    Clin Cancer Res; 2000 Aug; 6(8):3193-8. PubMed ID: 10955803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer.
    Hansen LL; Yilmaz M; Overgaard J; Andersen J; Kruse TA
    Cancer Res; 1998 May; 58(10):2166-9. PubMed ID: 9605761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity accumulation in primary breast carcinomas and additionally in corresponding distant metastases is associated with poor outcome.
    Hampl M; Hampl JA; Reiss G; Schackert G; Saeger HD; Schackert HK
    Clin Cancer Res; 1999 Jun; 5(6):1417-25. PubMed ID: 10389927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant loss of heterozygosity at the BRCA1 and FHIT genes as a prognostic factor in sporadic breast cancer.
    Silva Soares EW; de Lima Santos SC; Bueno AG; Cavalli IJ; Cavalli LR; Fouto Matias JE; de Souza Fonseca Ribeiro EM
    Cancer Genet Cytogenet; 2010 May; 199(1):24-30. PubMed ID: 20417865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity and allelic imbalance in apocrine adenosis of the breast.
    Selim AG; Ryan A; El-Ayat GA; Wells CA
    Cancer Detect Prev; 2001; 25(3):262-7. PubMed ID: 11425268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancer.
    Hirano A; Emi M; Tsuneizumi M; Utada Y; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Haga S; Kajiwara T; Nakamura Y
    Clin Cancer Res; 2001 Apr; 7(4):876-82. PubMed ID: 11309336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic loss in chromosomal region 1q21-23 in breast cancer is associated with peritumoral angiolymphatic invasion and extensive intraductal component.
    Gaki V; Tsopanomichalou M; Sourvinos G; Tsiftsis D; Spandidos DA
    Eur J Surg Oncol; 2000 Aug; 26(5):455-60. PubMed ID: 11016465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics Consortium.
    Laake K; Launonen V; Niederacher D; Gudlaugsdottir S; Seitz S; Rio P; Champème MH; Bièche I; Birnbaum D; White G; Sztan M; Sever N; Plummer S; Osorio A; Broeks A; Huusko P; Spurr N; Borg A; Cleton-Jansen AM; van't Veer L; Benitez J; Casey G; Peterlin B; Olah E; Børresen-Dale AL
    Genes Chromosomes Cancer; 1999 Jul; 25(3):212-21. PubMed ID: 10379867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two prognostic groups of inflammatory breast cancer have distinct genotypes.
    Lerebours F; Bertheau P; Bieche I; Plassa LF; Champeme MH; Hacene K; Toulas C; Espie M; Marty M; Lidereau R
    Clin Cancer Res; 2003 Sep; 9(11):4184-9. PubMed ID: 14519644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ductal carcinoma in situ of the breast with different histopathological grades and corresponding new breast tumour events: analysis of loss of heterozygosity.
    Smeds J; Wärnberg F; Norberg T; Nordgren H; Holmberg L; Bergh J
    Acta Oncol; 2005; 44(1):41-9. PubMed ID: 15848905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent allelic losses at 11q24.1-q25 in young women with breast cancer: association with poor survival.
    Gentile M; Olsen K; Dufmats M; Wingren S
    Br J Cancer; 1999 May; 80(5-6):843-9. PubMed ID: 10360664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast-cancer stromal cells with TP53 mutations and nodal metastases.
    Patocs A; Zhang L; Xu Y; Weber F; Caldes T; Mutter GL; Platzer P; Eng C
    N Engl J Med; 2007 Dec; 357(25):2543-51. PubMed ID: 18094375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATBF1-a messenger RNA expression is correlated with better prognosis in breast cancer.
    Zhang Z; Yamashita H; Toyama T; Sugiura H; Ando Y; Mita K; Hamaguchi M; Kawaguchi M; Miura Y; Iwase H
    Clin Cancer Res; 2005 Jan; 11(1):193-8. PubMed ID: 15671546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genome-wide map showing common regions of loss of heterozygosity/allelic imbalance in breast cancer.
    Osborne RJ; Hamshere MG
    Cancer Res; 2000 Jul; 60(14):3706-12. PubMed ID: 10919637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular tumor DNA in plasma and overall survival in breast cancer patients.
    Garcia JM; Garcia V; Silva J; Peña C; Dominguez G; Sanchez A; Sanfrutos L; Provencio M; Millan I; Chaparro D; España P; Bonilla F
    Genes Chromosomes Cancer; 2006 Jul; 45(7):692-701. PubMed ID: 16607614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Fragile Histidine Triad gene and breast cancer.
    Yang Q; Yoshimura G; Sakurai T; Kakudo K
    Med Sci Monit; 2002 Jul; 8(7):RA140-4. PubMed ID: 12118213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.